Recommended Dose of Pregabalin for Postoperative Pain Management
For postoperative pain management, pregabalin should be administered at a dose of 150 mg twice daily, starting before surgery and continuing for several days postoperatively. 1, 2
Adult Dosing Recommendations
- Initial pregabalin dose should be 50-75 mg twice daily or 75 mg twice daily, which can be titrated up to 300 mg/day in divided doses 1
- For optimal postoperative pain control, start with 150 mg pregabalin pre-operatively, followed by 75-150 mg twice daily for up to 7 days postoperatively 1, 2
- Maximum recommended dose is 600 mg/day (in divided doses), but higher dosages are not consistently more effective than 300 mg/day and are associated with greater adverse effects 1
- Dosage should be reduced in patients with renal insufficiency 1
Evidence for Efficacy in Postoperative Pain
Pregabalin 150 mg administered pre-operatively followed by twice-daily dosing postoperatively significantly reduces:
The lowest effective daily dose for postoperative analgesia is 225-300 mg/day 4
Perioperative pregabalin (150 mg twice daily) has been shown to attenuate preoperative anxiety, improve sleep quality, and reduce postoperative pain scores 5
Considerations for Specific Surgical Procedures
For total hip arthroplasty:
For total knee arthroplasty:
- Pregabalin 300 mg before surgery followed by 150-50 mg twice daily for 14 days postoperatively reduces the incidence of chronic neuropathic pain at 3 and 6 months 6
Adverse Effects and Precautions
Common side effects include:
Benefits of pregabalin administration:
Pregabalin is not recommended as routine medication for all patients due to clinically relevant side effects, particularly in elderly patients 1
Practical Administration Tips
- Start with lower dosages and titrate cautiously to reduce dizziness and sedation 1
- Pregabalin may provide analgesia more quickly than gabapentin because the initial dosage of 150 mg/day has been found efficacious in some trials 1
- In the United States, pregabalin is a Schedule V controlled substance 1
- An adequate trial of treatment with pregabalin's related compound gabapentin can require 2 months or more, suggesting that longer-term therapy may be beneficial in some cases 1